Dr Reddy’s gets EU approval for osteoporosis drug AVT03, a biosimilar to Prolia and Xgeva

Dr Reddy’s has secured European Commission approval for AVT03, its biosimilar version of Prolia and Xgeva—medicines used to treat osteoporosis and prevent bone complications in cancer patients.

Source link